It downregulates BMP-4 expression and inhibits hepatic stellate cell activation to inhibit liver fibrosis; it inhibits the expression of hepatic pro-inflammatory cytokines and the NF-κB signal pathway and increases the expression of anti-inflammatory cytokine IL-10, thereby inhibiting liver injury. Here, NFKB1 is linked to Hepatic fibrosis.